Melmotte, Inc.
Records under this name other than patents Melmotte, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,096,713 | Pharmaceutical angiostatic dipeptide compositions and methods of use thereof Term ended Term ended Mar 1, 2019 · From the USPTO record | Term ended | Term ended Mar 1, 2019 | From the USPTO record |
| US 6,139,862 | Pharmaceutical dipeptide compositions and methods of use thereof Term ended Term ended Apr 8, 2018 · From the USPTO record | Term ended | Term ended Apr 8, 2018 | From the USPTO record |
| US 6,100,380 | Immunomodulating peptides and methods of use Term ended Term ended Aug 8, 2017 · From the USPTO record | Term ended | Term ended Aug 8, 2017 | From the USPTO record |
| US 6,066,622 | Immunomodulating peptides and methods of use Term ended Term ended May 23, 2017 · From the USPTO record | Term ended | Term ended May 23, 2017 | From the USPTO record |
| US 6,136,788 | Pharmaceutical preparation for the therapy of immune deficiency conditions Lapsed on the fee record Ended Oct 24, 2012 · From the USPTO record | Lapsed on the fee record | Ended Oct 24, 2012 | From the USPTO record |
| US 6,368,788 | Method of treating complications in immunodepressed states resulting from HIV infection Term ended Term ended Apr 1, 2011 · From the USPTO record | Term ended | Term ended Apr 1, 2011 | From the USPTO record |
| US 6,346,514 | Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof Lapsed on the fee record Ended Feb 12, 2010 · From the USPTO record | Lapsed on the fee record | Ended Feb 12, 2010 | From the USPTO record |
| US 6,911,431 | Pharmaceutical angiostatic dipeptide compositions and methods of use thereof Term ended Ended no later than Aug 30, 2009 · From the USPTO record | Term ended | Ended no later than Aug 30, 2009 | From the USPTO record |
| US 6,777,195 | Pharmaceutical dipeptide compositions and methods of use thereof: immunostimulants Term ended Term ended Mar 16, 2009 · From the USPTO record | Term ended | Term ended Mar 16, 2009 | From the USPTO record |
| US 6,060,452 | Analogs of L-Glu-L-Trp having pharmacological activity Lapsed on the fee record Ended May 9, 2008 · From the USPTO record | Lapsed on the fee record | Ended May 9, 2008 | From the USPTO record |